Goodwin advised Nimbus Therapeutics on the financing. Nimbus Therapeutics announced its $210 million private financing to advance its next wave of tech-enabled small molecule medicines. The...
Nimbus Therapeutics’ $210 Million Private Financing
CardioFocus’ Licensing and Distribution Agreement with Grand Pharma
Goodwin Procter advised CardioFocus, Inc. on the deal. CardioFocus, Inc. announced its licensing and distribution agreement with China Grand Pharmaceutical (Grand Pharma). The agreement provides a license...
Synaptics Incorporated’s Acquisition of DSP Group
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
RBC Bearings’ $2.9 Billion Acquisition of ABB’s DODGE Mechanical Power Transmission Business
Goodwin Procter advised RBC Bearings Incorporated on the deal, while Kirkland & Ellis advised ABB. RBC Bearings Incorporated (Nasdaq: ROLL) announced its definitive agreement to acquire the...
Intellia Therapeutics’ $690 Million Underwritten Public Offering
Goodwin Procter advised Intellia Therapeutics on the deal. Intellia Therapeutics, Inc. (Nasdaq: NTLA) announced its $690 million underwritten public offering on the heels of releasing the first-ever...
Nimbus Therapeutics’ $105 Million Private Financing Round
Goodwin Procter LLP advised Nimbus Therapeutics on the deal. Nimbus Therapeutics announced the closing of a $105 million private financing round which was led by BVF Partners...
EQT’s EUR 881 Million Voluntary Takeover Bid Over Solarpack Corporación Tecnológica, S.A.
Clifford Chance advised EQT on the deal. Cuatrecasas advised the selling shareholders. Solarpack is a multinational specialized in the development, financing, construction, operation and management of utility...
Centessa Pharmaceuticals’ $330 Million IPO
Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model...